Recent News
- Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com, with more than a dozen items to discuss on this week's podcast.Read Article


Links:

Links:
Dr. John Cush @RheumNow ( View Tweet)



Links:

Links:

Links:

Links:
Dr. John Cush @RheumNow ( View Tweet)
NEJM: Early Combo Monoclonal Antibody Therapy in COVID-19
NEJM has published the interim analysis of the REGN-COV2 trial, wherein an antibody cocktail reduced viral loads with less clinical consequences.
Read ArticleCombo Anti-Spike Protein Antibody for Mild to Moderate COVID-19
JAMA has published the BLAZE-1 study, showing significant SARS-CoV-2 viral load reduction at day 11 and less COVID-19 progression when combination anti-spike monoclonal antibody therapy (bamlanivimab and etesevimab) was given to mild to moderate, non-hospitalized COVID-19 patients.
Read Article
k dao @KDAO2011 ( View Tweet)

Links:
Dr. John Cush @RheumNow ( View Tweet)

Links:
Dr. John Cush @RheumNow ( View Tweet)

Links:
Dr. John Cush @RheumNow ( View Tweet)

Links:
Dr. John Cush @RheumNow ( View Tweet)

Dr. John Cush @RheumNow ( View Tweet)

Links:
Dr. John Cush @RheumNow ( View Tweet)

Links:

Links:
Dr. John Cush @RheumNow ( View Tweet)